NDC11 73362020101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73362-0201-01 | 73362-0201 |
| 73362-0201-1 | 73362-0201 |
| 73362-201-01 | 73362-201 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yuviwel | NAVEPEGRITIDE | Ascendis Pharma Endocrinology, Inc. | e01c1197-338f-414c-b804-808e129ebc8c | 2026-03-25 | Warnings, Adverse reactions | 73362-201-01 73362-201 73362020101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.